Dr. Reddy's gets FDA blessing for Elyxby

Adults with acute migraine with or without aura will soon have a new treatment available.

Dr. Reddy’s has received the Food and Drug Administration’s blessing for Elyxyb.

"We are excited about the approval of Elyxyb. It reaffirms our commitment to innovation and to develop meaningfully differentiated products that address significant unmet needs of patients and physicians, leading to better health outcomes," Dr. Reddy's CEO, Erez Israeli said. 

“Elyxub is an oral solution of celecoxib formulated using a self-micro emulsifying drug delivery system that improves solubility and bioavailability of the drug leading to better absorption. This allows for the administration of a lower dose without affecting bioavailability," Anil Namboodiripad, Dr. Reddy's SVP of proprietary products group, said.